Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease.
Moreno-Delgado D, Puigdellívol M, Moreno E, Rodríguez-Ruiz M, Botta J, Gasperini P, Chiarlone A, Howell LA, Scarselli M, Casadó V, Cortés A, Ferré S, Guzmán M, Lluís C, Alberch J, Canela EI, Ginés S, McCormick PJ.
Moreno-Delgado D, et al. Among authors: mccormick pj.
Elife. 2020 Jun 9;9:e51093. doi: 10.7554/eLife.51093.
Elife. 2020.
PMID: 32513388
Free PMC article.